“Economic Evaluation of FDA-Approved Small Molecule Protein Kinase Inhibitors in Oncology and Non-Oncology Indications in the United States”, IAJLB, vol. 20, no. 1, pp. 20–51, Feb. 2023, Accessed: Oct. 16, 2026. Available: https://iajlb.org/index.php/iajlb/article/view/157